We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Read MoreHide Full Article
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.
In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.
One company to watch right now is Phibro Animal Health (PAHC - Free Report) . PAHC is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A. The stock is trading with P/E ratio of 15.37 right now. For comparison, its industry sports an average P/E of 16.57. Over the last 12 months, PAHC's Forward P/E has been as high as 16.56 and as low as 7.98, with a median of 12.28.
Investors will also notice that PAHC has a PEG ratio of 1.20. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. PAHC's PEG compares to its industry's average PEG of 1.76. Within the past year, PAHC's PEG has been as high as 1.74 and as low as 0.30, with a median of 0.50.
Value investors also use the P/S ratio. The P/S ratio is calculated as price divided by sales. Some people prefer this metric because sales are harder to manipulate on an income statement. This means it could be a truer performance indicator. PAHC has a P/S ratio of 0.9. This compares to its industry's average P/S of 1.62.
Investors could also keep in mind VAREX IMAGING (VREX - Free Report) , another Medical - Products stock with a Zacks Rank of #2 (Buy) and Value grade of A.
VAREX IMAGING is trading at a forward earnings multiple of 12.78 at the moment, with a PEG ratio of 2.47. This compares to its industry's average P/E of 16.57 and average PEG ratio of 1.76.
Furthermore, VAREX IMAGING holds a P/B ratio of 1.08 and its industry's price-to-book ratio is 2.36. VREX's P/B has been as high as 1.24, as low as 0.50, with a median of 0.94 over the past 12 months.
These are just a handful of the figures considered in Phibro Animal Health and VAREX IMAGING's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that PAHC and VREX is an impressive value stock right now.
View the Zacks #1 Rank List
Image: Bigstock
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.
In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.
One company to watch right now is Phibro Animal Health (PAHC - Free Report) . PAHC is currently sporting a Zacks Rank #2 (Buy), as well as a Value grade of A. The stock is trading with P/E ratio of 15.37 right now. For comparison, its industry sports an average P/E of 16.57. Over the last 12 months, PAHC's Forward P/E has been as high as 16.56 and as low as 7.98, with a median of 12.28.
Investors will also notice that PAHC has a PEG ratio of 1.20. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. PAHC's PEG compares to its industry's average PEG of 1.76. Within the past year, PAHC's PEG has been as high as 1.74 and as low as 0.30, with a median of 0.50.
Value investors also use the P/S ratio. The P/S ratio is calculated as price divided by sales. Some people prefer this metric because sales are harder to manipulate on an income statement. This means it could be a truer performance indicator. PAHC has a P/S ratio of 0.9. This compares to its industry's average P/S of 1.62.
Investors could also keep in mind VAREX IMAGING (VREX - Free Report) , another Medical - Products stock with a Zacks Rank of #2 (Buy) and Value grade of A.
VAREX IMAGING is trading at a forward earnings multiple of 12.78 at the moment, with a PEG ratio of 2.47. This compares to its industry's average P/E of 16.57 and average PEG ratio of 1.76.
Furthermore, VAREX IMAGING holds a P/B ratio of 1.08 and its industry's price-to-book ratio is 2.36. VREX's P/B has been as high as 1.24, as low as 0.50, with a median of 0.94 over the past 12 months.
These are just a handful of the figures considered in Phibro Animal Health and VAREX IMAGING's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that PAHC and VREX is an impressive value stock right now.